Intelligence / Healthtech / Health Funding Register / Cloverleaf Bio, Inc.
Fundingraised $14.8M9 Sept 2026
Cloverleaf Bio, Inc.
9 Sept 2026: Raised $14.8M · New Haven, CT. Recorded in the SEC Form D data sets.
- Filed
- 9 Sept 2026
- Location
- New Haven, CT
- State
- Connecticut
- Industry
- Biotechnology
- Amount raised
- $14.8M
- Offering size
- $29.6M
- Revenue range
- Decline to Disclose
- Year of incorporation
- 2023
- Entity type
- Corporation
- Jurisdiction
- Delaware
- First sale
- 2026-08-24
- Securities
- Equity
- Investors so far
- 12
- SEC CIK
- 0002153574
What this signal means
Companies buy in the months after they raise: new hires, new vendors, new markets.
- 137 added in the 30 days to 30 Sept 2026.
- 114 of them (29%) raised $5M or more.
Reach them with AOS
Find the decision makers at Cloverleaf Bio, Inc.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this funding signal, for your approval.
More from Connecticut
Health Funding Register
3 SeptInventure, LLCraised $82K · Southbury, CTFunding3 SeptPantera, Inc.raised $1.4M · Hartford, CTFunding20 AugOxbridge Health, Inc.raised $38.5M · Norwalk, CTFunding7 AugConvexity Scientific Inc.raised $10.0M · New Haven, CTFunding24 JulTECLens, Inc.raised $5.2M · Stamford, CTFunding23 JulUrologic Design, LLCraised $610K · Branford, CTFunding
Source: SEC Form D data sets, data to 30 Sept 2026. New Form D notices filed in Q3 2026 by health and life-sciences companies; pooled investment funds and amendments excluded. Amounts are as reported to the SEC. AOS shows what the public record says; it does not verify or endorse the company.